Ikarian Capital »

Relmada Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $167k 40k 4.14
2023-09-30 $121k 40k 3.00
2023-06-30 $161k 66k 2.46
2023-03-31 $148k 66k 2.26
2022-12-31 $229k 66k 3.49
2022-09-30 $57M 1.6M 37.02
2022-06-30 $11M 582k 18.99
2022-03-31 $588k 22k 26.97
2021-12-31 $467k 21k 22.51
2021-09-30 $544k 21k 26.23
2021-06-30 $16M 504k 32.01
2021-03-31 $17M 488k 35.21
2020-03-31 $1.9M 55k 34.11